Moubarak Ghassan, Maison-Blanche Pierre, Thomas Olivier
Department of Electrophysiology and Pacing, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France.
Department of Electrophysiology and Pacing, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France.
J Electrocardiol. 2018 May-Jun;51(3):531-533. doi: 10.1016/j.jelectrocard.2017.12.005. Epub 2017 Dec 8.
The eligibility for subcutaneous implantable cardioverter-defibrillators (S-ICD) was assessed among patients already implanted with cardiac resynchronization therapy (CRT). We included 20 patients (15 men, age 73±10years, LVEF 35±10%). Seventeen (85%) patients were eligible for S-ICDs: 11 (55%) patients on only 1 vector and 6 (30%) patients on 2 or 3 vectors. Patients who were eligible on 2-3 vectors had narrower paced QRS than patients who were not eligible or were eligible on only one vector (133±18ms vs 167±17ms, p=0.007). If necessary, S-ICD implantation could be considered in most patients with CRT.
在已植入心脏再同步治疗（CRT）的患者中评估了皮下植入式心律转复除颤器（S-ICD）的适用性。我们纳入了20例患者（15例男性，年龄73±10岁，左心室射血分数[LVEF] 35±10%）。17例（85%）患者适合植入S-ICD：11例（55%）患者仅在1个向量上适合，6例（30%）患者在2个或3个向量上适合。在2 - 3个向量上适合的患者，其起搏QRS波群比不适合或仅在1个向量上适合的患者更窄（133±18毫秒对167±17毫秒，p = 0.007）。如有必要，大多数接受CRT的患者可考虑植入S-ICD。
